Anti‐inflammatory effects of the novel inhaled phosphodiesterase type 4 inhibitor CHF6001 on virus‐inducible cytokines

類似資料

• Concentration–QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase‐4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation
  著者:: Jolling, Koen, 等
  出版事項: (2019)
• CHF6001 Inhibits NF-κB Activation and Neutrophilic Recruitment in LPS-Induced Lung Inflammation in Mice
  著者:: Stellari, Fabio F., 等
  出版事項: (2019)
• Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
  著者:: Singh, Dave, 等
  出版事項: (2019)
• Phosphodiesterase 4 inhibitors attenuate virus‐induced activation of eosinophils from asthmatics without affecting virus binding
  著者:: Sabogal Piñeros, Yanaika Shari, 等
  出版事項: (2020)
• Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study
  著者:: Singh, Dave, 等
  出版事項: (2020)